BACKGROUND: Quantitative sensory testing (QST) assesses the functional integrity of small and large nerve fibre afferents and central somatosensory pathways; QST was assumed to provide insight into the mechanisms of neuropathy. We analysed QST profiles and phenotypes in patients with diabetes mellitus to study whether these could differentiate patients with and without pain and neuropathy. METHODS: A standardized QST protocol was performed and 'loss and gain of function' abnormalities were analysed in four groups of subjects: diabetic patients with painful (pDSPN; n = 220) and non-painful distal symmetric polyneuropathy (nDSPN; n = 219), diabetic patients without neuropathy (DM; n = 23) and healthy non-diabetic subjects (n = 37). Based on the QST findings, diabetic subjects were further stratified into four predefined prototypic phenotypes: sensory loss (SL), thermal hyperalgesia (TH), mechanical hyperalgesia (MH) and healthy individuals. RESULTS: Patients in the pDSPN group showed the greatest hyposensitivity ('loss of function'), and DM patients showed the lowest, with statistically significant increases in thermal, thermal pain, mechanical and mechanical pain sensory thresholds. Accordingly, the frequency of the SL phenotype was significantly higher in the pDSPN subgroup (41.8%), than expected (p < 0.0042). The proportion of 'gain of function' abnormalities was low in both pDSPN and nDSPN patients without significant differences. CONCLUSIONS: There is a continuum in the sensory profiles of diabetic patients, with a more pronounced sensory loss in pDSPN group probably reflecting somatosensory nerve fibre degeneration. An analysis of 'gain of function' abnormalities (allodynia, hyperalgesia) did not offer a key to understanding the pathophysiology of spontaneous diabetic peripheral neuropathic pain. SIGNIFICANCE: This article, using quantitative sensory testing profiles in large cohorts of diabetic patients with and without polyneuropathy and pain, presents a continuum in the sensory profiles of diabetic patients, with more pronounced 'loss of function' abnormalities in painful polyneuropathy patients. Painful diabetic polyneuropathy probably represents a 'more progressed' type of neuropathy with more pronounced somatosensory nerve fibre degeneration. The proportion of 'gain of function' sensory abnormalities was low, and these offer limited understanding of pathophysiological mechanisms of spontaneous neuropathic pain.

Cancer Chelsea and Westminster Campus Imperial College London London UK

Central European Institute of Technology Masaryk University Brno Czech Republic

Department of Neurology Centre for Neuromuscular Diseases University Hospital Brno Brno Czech Republic

Department of Neurology University Medical Centre Mainz Germany

Department of Neurology University of Würzburg Germany

Faculty of Medicine Masaryk University Brno Czech Republic

Medical Faculty Mannheim Neurophysiology Centre for Biomedicine and Medical Technology Mannheim Ruprecht Karls University Heidelberg Germany

Pain Research Faculty of Medicine Department of Surgery and amp

000      

00000naa a2200000 a 4500

001      

bmc22032856

003      

CZ-PrNML

005      

20230131151137.0

007      

ta

008      

230120s2022 enk f 000 0|eng||

009      

AR

024    7_

$a 10.1002/ejp.2034 $2 doi

035    __

$a (PubMed)36069121

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a enk

100    1_

$a Raputova, Jana $u Department of Neurology, Centre for Neuromuscular Diseases (Associated National Centre in the European Reference Network ERN EURO-NMD), University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic

245    10

$a Continuum of sensory profiles in diabetes mellitus patients with and without neuropathy and pain / $c J. Raputova, A. Rajdova, J. Vollert, I. Srotova, C. Rebhorn, N. Üçeyler, F. Birklein, C. Sommer, E. Vlckova, J. Bednarik

520    9_

$a BACKGROUND: Quantitative sensory testing (QST) assesses the functional integrity of small and large nerve fibre afferents and central somatosensory pathways; QST was assumed to provide insight into the mechanisms of neuropathy. We analysed QST profiles and phenotypes in patients with diabetes mellitus to study whether these could differentiate patients with and without pain and neuropathy. METHODS: A standardized QST protocol was performed and 'loss and gain of function' abnormalities were analysed in four groups of subjects: diabetic patients with painful (pDSPN; n = 220) and non-painful distal symmetric polyneuropathy (nDSPN; n = 219), diabetic patients without neuropathy (DM; n = 23) and healthy non-diabetic subjects (n = 37). Based on the QST findings, diabetic subjects were further stratified into four predefined prototypic phenotypes: sensory loss (SL), thermal hyperalgesia (TH), mechanical hyperalgesia (MH) and healthy individuals. RESULTS: Patients in the pDSPN group showed the greatest hyposensitivity ('loss of function'), and DM patients showed the lowest, with statistically significant increases in thermal, thermal pain, mechanical and mechanical pain sensory thresholds. Accordingly, the frequency of the SL phenotype was significantly higher in the pDSPN subgroup (41.8%), than expected (p &lt; 0.0042). The proportion of 'gain of function' abnormalities was low in both pDSPN and nDSPN patients without significant differences. CONCLUSIONS: There is a continuum in the sensory profiles of diabetic patients, with a more pronounced sensory loss in pDSPN group probably reflecting somatosensory nerve fibre degeneration. An analysis of 'gain of function' abnormalities (allodynia, hyperalgesia) did not offer a key to understanding the pathophysiology of spontaneous diabetic peripheral neuropathic pain. SIGNIFICANCE: This article, using quantitative sensory testing profiles in large cohorts of diabetic patients with and without polyneuropathy and pain, presents a continuum in the sensory profiles of diabetic patients, with more pronounced 'loss of function' abnormalities in painful polyneuropathy patients. Painful diabetic polyneuropathy probably represents a 'more progressed' type of neuropathy with more pronounced somatosensory nerve fibre degeneration. The proportion of 'gain of function' sensory abnormalities was low, and these offer limited understanding of pathophysiological mechanisms of spontaneous neuropathic pain.

650    12

$a diabetes mellitus $7 D003920

650    12

$a diabetické neuropatie $7 D003929

650    _2

$a lidé $7 D006801

650    _2

$a hyperalgezie $x etiologie $7 D006930

650    12

$a neuralgie $7 D009437

650    _2

$a měření bolesti $x metody $7 D010147

650    _2

$a práh bolesti $x fyziologie $7 D017288

650    12

$a polyneuropatie $7 D011115

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Rajdova, Aneta $u Department of Neurology, Centre for Neuromuscular Diseases (Associated National Centre in the European Reference Network ERN EURO-NMD), University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic

700    1_

$a Vollert, Jan $u Pain Research, Faculty of Medicine, Department of Surgery &amp; Cancer, Chelsea and Westminster Campus, Imperial College London, London, UK $u Medical Faculty Mannheim, Neurophysiology, Centre for Biomedicine and Medical Technology Mannheim (CBTM), Ruprecht-Karls-University, Heidelberg, Germany

700    1_

$a Srotova, Iva $u Department of Neurology, Centre for Neuromuscular Diseases (Associated National Centre in the European Reference Network ERN EURO-NMD), University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic

700    1_

$a Rebhorn, Cora $u Department of Neurology, University Medical Centre, Mainz, Germany

700    1_

$a Üçeyler, Nurcan $u Department of Neurology, University of Würzburg, Germany

700    1_

$a Birklein, Frank $u Department of Neurology, University Medical Centre, Mainz, Germany

700    1_

$a Sommer, Claudia $u Department of Neurology, University of Würzburg, Germany

700    1_

$a Vlckova, Eva $u Department of Neurology, Centre for Neuromuscular Diseases (Associated National Centre in the European Reference Network ERN EURO-NMD), University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic

700    1_

$a Bednarik, Josef $u Department of Neurology, Centre for Neuromuscular Diseases (Associated National Centre in the European Reference Network ERN EURO-NMD), University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000174202383

773    0_

$w MED00158145 $t European journal of pain (London, England) $x 1532-2149 $g Roč. 26, č. 10 (2022), s. 2198-2212

856    41

$u https://pubmed.ncbi.nlm.nih.gov/36069121 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20230120 $b ABA008

991    __

$a 20230131151133 $b ABA008

999    __

$a ok $b bmc $g 1891540 $s 1184191

BAS    __

$a 3

BAS    __

$a PreBMC-MEDLINE

BMC    __

$a 2022 $b 26 $c 10 $d 2198-2212 $e 20220915 $i 1532-2149 $m European journal of pain $n Eur J Pain $x MED00158145

LZP    __

$a Pubmed-20230120